Months into the COVID-19 pandemic, the public seems more confused than ever. And health officials still are not all on the same page; this week the World Health Organization had to walk back an official’s statement about how commonly the virus is spread by people without symptoms. Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss this and more. Also, Rovner interviews Michael Mackert, a professor and health communications expert at the University of Texas-Austin, about how health information can best be translated to the public.
This is a tactic that we’ve seen before.
Sen. Kyrsten Sinema has received almost $100,000 from drug companies in the current election cycle, a KHN analysis shows, one of the largest cash hauls in Congress. And it’s only her first term.
Democrats were not impressed with the Trump administration’s COVID-19 national testing strategy document submitted to Congress this week. They say the pandemic requires more direction from the federal government, while the administration wants to give nearly all the responsibility to the states. Meanwhile, in an effort to shore up his base of senior voters, President Donald Trump has unveiled a plan to limit what those on Medicare must pay out-of-pocket for insulin. Anna Edney of Bloomberg News, Erin Mershon of STAT News and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss this and more. Also, Rovner interviews KHN’s Phil Galewitz, who wrote the latest KHN-NPR “Bill of the Month” installment about a patient who thought he might have COVID-19, did everything right and got a big bill, anyway.
House Democrats unveiled legislation that would effectively double what the federal government has spent on relief for the COVID-19 pandemic, but Republicans say they want to wait before even talking about another bill. Meanwhile, a key Republican senator called the GOP court case challenging the Affordable Care Act “flimsy.” Rebecca Adams of CQ Roll Call and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss this and more.
Frustration from inside the Trump administration over the management of the COVID-19 pandemic is starting to become public, as whistleblowers ― some anonymous, some named — tell how the effort is being undermined by favoritism, incompetence and a disdain for science. Meanwhile, the Supreme Court heard a case that could threaten the Affordable Care Act’s birth control benefit. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News and Rachana Pradhan of Kaiser Health News join KHN’s Julie Rovner to discuss this and more. Also, for “extra credit,” the panelists recommend their favorite stories of the week they think you should read, too.
The Supreme Court this week, in an 8-1 decision, ruled that insurers are due the roughly $12 billion that Congress several years ago tried to cut off in payments under the Affordable Care Act’s “risk corridors” provision. And while the COVID-19 pandemic continues to rage in many places around the country, states are starting to reopen their economies at the urging of President Donald Trump and over objections of public health officials. Caitlin Owens of Axios and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss this and more. Also, Rovner interviews KHN’s Carmen Heredia Rodriguez, who wrote the latest KHN-NPR “Bill of the Month” installment about COVID testing that should have been free but was not.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
The messaging from the White House coronavirus press briefings is becoming more confusing as President Donald Trump and his science advisers appear to not see eye to eye. Meanwhile, Congress is ready to approve more money to address both the health and economic fallout of the COVID-19 pandemic. And the virus is taking an almost unimaginable toll on the nation’s nursing homes and putting strain on patients and health care providers with non-COVID ailments. Joanne Kenen of Politico, Jennifer Haberkorn of the Los Angeles Times and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these topics and more.
The politics of COVID-19 are pretty polarized, but health experts across the ideological spectrum agree: The U.S. will need more robust testing before it’s safe to relax social-distancing requirements. Meanwhile, President Donald Trump, Congress and the nation’s governors continue to spar over who should be responsible for what. Kimberly Leonard of Business Insider, Tami Luhby of CNN and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss this and more. Also, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.